Key result
Knockdown of LncRNA RP11-708J19.2 reduces colorectal cancer cell viability and increases apoptosis via SIRT7-mediated acetylation.
Why the study?
Recent GWAS identified a CRC susceptibility locus at 3p21.31, but the functional SNP(s) underlying this association remained to be elucidated.
p-value: p=<0.01
The lncRNA RP11-708J19.2 promotes colorectal cancer progression via a SIRT7-mediated epigenetic pathway, offering a novel biomarker and therapeutic target.
Hypothesis-generating for RP11-708J19.2 targeting in colorectal cancer; leaves open clinical translation of SIRT7-H3K18ac effects.
Colorectal cancer (CRC) is a prevalent malignancy with a complex genetic basis. Recent genome-wide association studies (GWAS) have identified a susceptibility locus at 3p21.31, however, the functional SNP(s) underlying the association between the 3p21.31 region and CRC remain to be elucidated. In this study, we identified rs2101247 as the potential functional SNP and further demonstrated that rs2101247 is significantly associated with the expression of the nearby long non-coding RNA (lncRNA) RP11-708J19.2 (ENSG00000271161.1). Functional experiments showed that RP11-708J19.2 is upregulated in CRC tumor tissues, and its knockdown reduces cell viability while promoting apoptosis in SW1116 and HCT116 cell lines. Mechanistically, RP11-708J19.2 interacts directly with the deacetylase SIRT7, modulating histone H3K18 acetylation (H3K18ac). Specifically, RP11-708J19.2 knockdown leads to a significant upregulation of H3K18ac levels, implicating a SIRT7-mediated epigenetic pathway in CRC progression. Our findings elucidate a novel functional SNP-lncRNA axis that contributes to CRC pathogenesis, providing potential biomarkers for early detection and therapeutic targets for intervention.
No takes yet. Share an insight, caveat, or question.
J et al. (2026) studied Colorectal cancer (n=90). LncRNA RP11-708J19.2 knockdown vs. Negative control siRNA was evaluated on Cell viability and apoptosis (p=<0.01). Knockdown of LncRNA RP11-708J19.2 significantly reduced cell viability and increased apoptosis in colorectal cancer cell lines by modulating SIRT7-mediated H3K18 acetylation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: